| Gene Symbol | Dementia |
| Accurate diagnosis | Clinical diagnostic accuracy for DLB is only ~50-80%, biomarkers improve this significantly |
| Differential diagnosis | Helps distinguish DLB from AD, PDD, and other dementias |
| Disease staging | Biomarkers can track disease progression and severity |
| Treatment selection | guides medication choices (e.g., cholinesterase inhibitors, antipsychotic sensitivity) |
| Clinical trial enrichment | Enables identification of appropriate patient populations |
| Prognostic assessment | Predicts cognitive decline rate and survival outcomes |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis, Anxiety |
| KG Connections | 2440 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!